Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Clinical Outcomes Following Atherectomy of Calcified Left Main Coronary

Lookup NU author(s): Dr Ayman Al-atta, Dr Bilal Bawamia, Dr Mohammad Alkhalil, Dr Mohaned Egred

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Copyright © 2025 Mohamed Farag et al. Journal of Interventional Cardiology published by John Wiley & Sons Ltd.Introduction: Plaque modifying-debulking devices are the most effective initial strategy for percutaneous coronary intervention of severely calcified lesions including left main coronary artery. There are limited data comparing the short- and long-term clinical outcomes of these devices in left main lesions. Methods: A retrospective analysis of patients with calcified left main lesions treated with percutaneous intervention with adjunctive plaque modifying device at a large tertiary center between 2008 and 2021. The primary endpoint was long-term mortality at documented longest follow-up. Secondary endpoints included procedural complications and in-hospital clinical outcome. Results: A total of 302 patients with calcified left main lesions treated with rotational atherectomy (RA) (n = 240), intracoronary lithotripsy (n = 30), or excimer laser coronary atherectomy (n = 32) were included. Out of all patients, 55% presented with acute coronary syndromes. Technical success was achieved in 98.7% of the patients and procedural success was achieved in 95.4% of the patients. At a median follow-up of 42 (19–62) months, there was no difference in mortality between the 3 devices (RA 54/240 [23.4%] vs. lithotripsy 1/30 [3.3%] vs. laser 5/32 [15.6%], p = 0.128). Likewise, in-hospital clinical outcomes were similar. However, procedural complications were higher in the laser group. Conclusions: In patients with calcified left main lesions treated with percutaneous intervention, adjunctive plaque-modifying devices appear safe with survival exceeding 80% at long-term follow-up with no difference between the devices in relation to in-hospital clinical outcomes or long-term mortality risk.


Publication metadata

Author(s): Farag M, Gungoren F, Al-Atta A, Abdalazeem I, Bawamia B, Alkhalil M, Egred M

Publication type: Article

Publication status: Published

Journal: Journal of Interventional Cardiology

Year: 2025

Volume: 2025

Issue: 1

Online publication date: 14/07/2025

Acceptance date: 16/06/2025

Date deposited: 28/07/2025

ISSN (print): 0896-4327

ISSN (electronic): 1540-8183

Publisher: John Wiley and Sons Inc

URL: https://doi.org/10.1155/joic/9605550

DOI: 10.1155/joic/9605550

Data Access Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request


Altmetrics

Altmetrics provided by Altmetric


Share